Blog
RSS FeedPosted by Michael Wonder on 25 Jun 2018
PBS push for stage-three melanoma drug
25 June 2018 - After witnessing family members succumb to cancer, Melbourne man Peter Gourlay was determined to do whatever ...
Posted by Michael Wonder on 25 Jun 2018
HealthEngine patients’ exposure: when on line is out of line
25 June 2018 - The revelation that the doctor appointments company, HealthEngine, has reportedly shared hundreds of patient details with ...
Posted by Michael Wonder on 25 Jun 2018
Health care access Australians’ top concern
25 June 2018 - The top priority Australians give to good health care and public hospitals should remind our political ...
Posted by Michael Wonder on 25 Jun 2018
Grudge against health premiums grows-ACCC
25 June 2018 - The Australian Competition and Consumer Commission has shed light on skyrocketing private health insurance premiums and it's ...
Posted by Michael Wonder on 24 Jun 2018
Industry urges EU to scrap national HTA bodies
22 June 2018 - The pharma industry has called for European member states’ national drug value assessment bodies to be ...
Posted by Michael Wonder on 24 Jun 2018
Agenda for June 27 TC meeting
22 June 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 23 Jun 2018
Depression in adults: campaigners and doctors demand full revision of NICE guidance
20 June 2018 - A coalition of mental health organisations and individual clinicians has described the latest draft guidelines on ...
Posted by Michael Wonder on 22 Jun 2018
Sanofi’s Dupixent approved for routine NHS use
22 June 2018 - Adults with moderate to severe atopic dermatitis are a step closer to being able to routinely ...
Posted by Michael Wonder on 22 Jun 2018
Bob Katter wants Keytruda added to PBS
22 June 2018 - With breast cancer and Hodgkin lymphoma drugs added to the Pharmaceutical Benefits Scheme Kennedy MP Bob ...
Posted by Michael Wonder on 22 Jun 2018
NICE backs Ocrevus but primary-progressive group kept waiting
22 June 2018 - NICE published a positive final appraisal determination on Friday for Ocrevus (ocrelizumab) to treat people living ...
Posted by Michael Wonder on 21 Jun 2018
Whistler woman forced to fundraise for cancer drugs
21 June 2018 - Joni Denroche staying positive after insurance fails to cover needed treatment. ...
Posted by Michael Wonder on 21 Jun 2018
Confirmatory versus explorative endpoint analysis: decision-making on the basis of evidence available from market authorisation and early benefit assessment for oncology drugs
21 June 2018 - The early benefit assessment of pharmaceuticals in Germany and their preceding market authorisation pursue different objectives. ...
Posted by Michael Wonder on 21 Jun 2018
Script for a healthier Australia: small steps and big savings
20 June 2018 - The latest Australia’s Health report provides persuasive evidence for a concerted national strategy to counter obesity ...
Posted by Michael Wonder on 21 Jun 2018
Ramsay's profit downgrade a sign of trouble in health
21 June 2018 - Ramsay Health Care's profit is ominous because it adds to the evidence that Australia's private health ...
Posted by Michael Wonder on 21 Jun 2018
Australian Stage 3 melanoma patients forced to self-fund recurrent treatment while PBS makes decision on listing
21 June 2018 - An Australian man has described the staggering decision to pay $100,000 for a treatment that could mean ...